Hikal Limited
Hikal Limited
Acción · INE475B01022 (XBOM)
Resumen
Sin cotización
Precio de cierre XBOM 27.10.2025: 242,00 INR
27.10.2025 09:59
Cotizaciones actuales de Hikal Limited
BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XBOM: MSE
MSE
HIKAL.BO
INR
27.10.2025 09:59
242,00 INR
-0,10 INR
-0,04 %
Flotación y Liquidez de las Acciones
Flotación Libre 30,88 %
Acciones en Flotación 38,07 M
Acciones en Circulación 123,29 M
Perfil de la empresa para Hikal Limited Acción
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India. The company operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. It also collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, the company offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. It also exports its products. The company operates in the United States, Canada, Europe Union, Japan, Latin America, and internationally. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Obtén información actualizada de finAgent sobre Hikal Limited

Datos de la empresa

Nombre Hikal Limited
Empresa Hikal Limited
Sitio web https://www.hikal.com
Mercado principal XBOM MSE
ISIN INE475B01022
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - Specialty & Generic
CEO Jai Vishwanath Hiremath
Capitalización de mercado 33 Mrd.
País India
Moneda INR
Empleados 2,1 T
Dirección Great Eastern Chambers, 400614 Navi Mumbai
Fecha de OPV 2002-07-01
Dividendos de 'Hikal Limited'
Fecha ex-dividendo Dividendo por acción
02.09.2025 0,80 INR

Símbolos de cotización

Nombre Símbolo
MSE HIKAL.BO
Otras acciones
Los inversores que tienen Hikal Limited también tienen las siguientes acciones en su cartera:
ASFINAG 24/34 MTN
ASFINAG 24/34 MTN Bono
Showa Sangyo Co., Ltd.
Showa Sangyo Co., Ltd. Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025